New findings from the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS)

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 5, 2007, Pages 543-546

  Riddle, Mark A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; METHYLPHENIDATE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25;

ATTENTION DEFICIT DISORDER; COMORBIDITY; COMPULSION; DECREASED APPETITE; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; EMOTIONAL DISORDER; GENETIC ASSOCIATION; HUMAN; IRRITABILITY; OUTCOME ASSESSMENT; PHARMACOGENETICS; PRESCHOOL CHILD; RECEPTOR GENE; SIDE EFFECT; SLEEP DISORDER; SOCIAL ADAPTATION; STATISTICAL SIGNIFICANCE; THOUGHT DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 35848952754     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2007.17501     Document Type: Editorial

References (14)

1. Abikoff HB, Vitiello B, Riddle MA,Cunningham C, Greenhill LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kollins SH, McCracken JT, McGough JJ, Murray DW, Posner K, Skrobala AM, Wigal T: Methylphenidate effects on functional outcome in preschoolers with attention-deficit/hyperactivity disorder: Results from the National Institute of Mental Preschoolers with Attention Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:581-592, 2007.
2. Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Scharko AM, McGough JJ, Murray DW, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM: Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:563-579, 2007.
3. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284-1293, 2006.
4. Hardy KK, Kollins SH, Murray DW, Riddle MA, Greenhill LL, Cunningham C, Abikoff HB, McCracken JT, Vitiello B, Davies M,, McGough JJ, Posner K, Skorbala AM, Swanson JM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ: Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:621-633, 2007.
5. Kollins S, Green L, Swanson J, Wigal S, Abikoff H, McCracken J, Riddle M, McGough J, Vitiello B, Wigal T, Skrobala A, Posner K, Ghuman J, Davies M, Cunningham C, Bauzo A: Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry 45:1275-1283, 2006.
6. McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Cunningham C, Shigawa S, Moyzis R, Vitiello B: Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1314-1322, 2006.
7. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
8. MTA Cooperative Group: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769, 2004.
9. Murray D, Kollins SH, Hardy KK, Abikoff HB, Swanson JM, Cunningham C, Vitiello B, Riddle MA, Davies M, Greenhill LL, McCracken JT, McGough JJ, Posner K, Skrobala AM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ: Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:605-619, 2007.
10. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala AM, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins SH, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL: Clinical presentation of attention-deficit/ hyperactivity disorder in preschool children: The Preschool Attention-Deficit/ Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:547-562, 2007.
11. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCracken J, McGough J, Riddle M, Ghuman J, Cunningham C, Wigal S: Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry 45:1304-1313, 2006.
12. Swanson JM, Moyzis RK, McGough JJ, McCracken JT, Riddle MA, Kollins SH, Greenhill LL, Abikoff HB, Wigal T, Wigal SB, Posner K, Skrobala AM, Ghuman JK, Cunningham C, Vitiello B, Stehli A, Smalley SL, Grady D: Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:635-645, 2007.
13. Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, Swanson JM, Wigal T, McGough JJ, Ghuman JK, Wigal SB, Skrobala AM, Davies M, Posner K, Cunningham C, Greenhill LL: Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/ Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharm 17:593-603, 2007.
14. Wigal T, Greenhill L, Chuang S, McGough J, Vitiello B, Skrobala A, Swanson J, Wigal S, Abikoff H, Kollins S, McCracken J, Riddle M, Posner K, Ghuman J, Davies M, Thorp B, Stehli A: Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry 45: 1294-1302, 2006.